March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Bilateral Herpetic Keratoconjunctivitis in Cancer Patients
Author Affiliations & Notes
  • Elvia Canseco
    Ophthalmology, UT Houston Health Science Center (UTHSC), Houston, Texas
  • Janhavi Modak
    Ophthalmology Section/Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas
  • Ashley Kingham
    Ophthalmology Section/Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas
  • Venus Arevalo
    Ophthalmology Section/Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas
  • Stella K. Kim
    Ophthalmology Section/Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas
  • Footnotes
    Commercial Relationships  Elvia Canseco, None; Janhavi Modak, None; Ashley Kingham, None; Venus Arevalo, None; Stella K. Kim, None
  • Footnotes
    Support  Charles Griffenberg Memorial Fund
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6149. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elvia Canseco, Janhavi Modak, Ashley Kingham, Venus Arevalo, Stella K. Kim; Bilateral Herpetic Keratoconjunctivitis in Cancer Patients. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6149.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe bilateral herpetic keratoconjunctivitis in cancer patients from a tertiary hospital

Methods: : IRB -aproved retrospective review of patients who were diagnosed with herpetic keratoconjunctivitis (both simplex and zoster) from June 2001-August 2011 at MD Anderson Cancer Center was conducted. Of them, bilateral cases were reviewed. Extensive literature search was performed on bilateral herpetic cases.

Results: : 90 patients were diagnosed with herpetic simplex or zoster keratoconjunctivitis, of which 12 patients had bilateral disease (13.3%) with mean followup of 9.4 months (range 0.25 - 23). For the bilateral cases, the cancer diagnoses included leukemia (5), lymphoma/myeloma (5), breast (1) and colon cancer (1). 58% (7/12), 25% and 8% of patients had history of allogeneic stem cell transplantation (SCT), whole brain radiotherapy (XRT) including the orbits, and autologous SCT, respectively. 42% (5/12) patients were in remission from their cancer and 58% (7/12) were in active cancer treatment. Only 2 patients (16%) were not immunocompromised or suppressed (orbital XRT patients), but all others were either being actively treated for their relapsed cancer (with chemo/steroid) or immunosuppression after SCT (with tacrolimus/steroid). 58% (7/12) patients were on systemic steroids and 42% (5/12) were on prophylactic anti-viral medication at the time of presentation. 1 patient had disseminated herpetic disease and was on IV antiviral therapy. The diagnosis of herpetic disease was made clinically, and confirmatory rapid antigen immunofluorescence/or viral culture were positive in 10 cases (83.3%). Extensive literature search revealed bilateral cases of herpetic disease in atopic patients but none in cancer patient population.

Conclusions: : Bilateral herpetic keratoconjunctivits in cancer patients is described. This study marks first in the literature to describe bilateral HSV and HZV keratoconjunctivitis in cancer patients. It was most frequently observed in patients on systemic steroid and immunocompromised patient population despite prophylaxis for herpetic disease. Further studies are needed to eluciate predisposing factors for bilateral disease in this patient population.

Keywords: herpes simplex virus • keratitis • conjunctivitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×